These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25948718)

  • 1. Homozygous carriers of APP A713T mutation in an autosomal dominant Alzheimer disease family.
    Conidi ME; Bernardi L; Puccio G; Smirne N; Muraca MG; Curcio SA; Colao R; Piscopo P; Gallo M; Anfossi M; Frangipane F; Clodomiro A; Mirabelli M; Vasso F; Cupidi C; Torchia G; Di Lorenzo R; Mandich P; Confaloni A; Maletta RG; Bruni AC
    Neurology; 2015 Jun; 84(22):2266-73. PubMed ID: 25948718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AbetaPP A713T mutation in late onset Alzheimer's disease with cerebrovascular lesions.
    Bernardi L; Geracitano S; Colao R; Puccio G; Gallo M; Anfossi M; Frangipane F; Curcio SA; Mirabelli M; Tomaino C; Vasso F; Smirne N; Maletta R; Bruni AC
    J Alzheimers Dis; 2009; 17(2):383-9. PubMed ID: 19363265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene.
    Rossi G; Giaccone G; Maletta R; Morbin M; Capobianco R; Mangieri M; Giovagnoli AR; Bizzi A; Tomaino C; Perri M; Di Natale M; Tagliavini F; Bugiani O; Bruni AC
    Neurology; 2004 Sep; 63(5):910-2. PubMed ID: 15365148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis.
    Di Fede G; Catania M; Morbin M; Rossi G; Suardi S; Mazzoleni G; Merlin M; Giovagnoli AR; Prioni S; Erbetta A; Falcone C; Gobbi M; Colombo L; Bastone A; Beeg M; Manzoni C; Francescucci B; Spagnoli A; Cantù L; Del Favero E; Levy E; Salmona M; Tagliavini F
    Science; 2009 Mar; 323(5920):1473-7. PubMed ID: 19286555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic counseling and testing for families with Alzheimer's disease].
    Kowalska A
    Neurol Neurochir Pol; 2004; 38(6):495-501. PubMed ID: 15654674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Alzheimer disease associated with A713T mutation in APP.
    Armstrong J; Boada M; Rey MJ; Vidal N; Ferrer I
    Neurosci Lett; 2004 Nov; 370(2-3):241-3. PubMed ID: 15488330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
    Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
    J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val-->Ile mutation in the amyloid precursor protein gene.
    Mullan M; Tsuji S; Miki T; Katsuya T; Naruse S; Kaneko K; Shimizu T; Kojima T; Nakano I; Ogihara T
    Neurobiol Aging; 1993; 14(5):407-19. PubMed ID: 8247223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features.
    Giaccone G; Morbin M; Moda F; Botta M; Mazzoleni G; Uggetti A; Catania M; Moro ML; Redaelli V; Spagnoli A; Rossi RS; Salmona M; Di Fede G; Tagliavini F
    Acta Neuropathol; 2010 Dec; 120(6):803-12. PubMed ID: 20842367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening for mutations of the precursor of beta-amyloid protein in early forms of Alzheimer disease. French Study Group of Alzheimer Disease].
    Rev Neurol (Paris); 1993; 149(10):528-31. PubMed ID: 8023065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation.
    Wahlund LO; Basun H; Almkvist O; Julin P; Axelman K; Shigeta M; Jelic V; Nordberg A; Lannfelt L
    Dement Geriatr Cogn Disord; 1999; 10(6):526-33. PubMed ID: 10559570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual Segregation of APP Mutations in Monogenic Alzheimer Disease.
    Mastromoro G; Gambardella S; Marchionni E; Campopiano R; Traversa A; Di Bonaventura C; Pizzuti A
    Neurodegener Dis; 2019; 19(2):96-100. PubMed ID: 31578030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.
    Nilsberth C; Westlind-Danielsson A; Eckman CB; Condron MM; Axelman K; Forsell C; Stenh C; Luthman J; Teplow DB; Younkin SG; Näslund J; Lannfelt L
    Nat Neurosci; 2001 Sep; 4(9):887-93. PubMed ID: 11528419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?
    Hedrich K; Hagenah J; Djarmati A; Hiller A; Lohnau T; Lasek K; Grünewald A; Hilker R; Steinlechner S; Boston H; Kock N; Schneider-Gold C; Kress W; Siebner H; Binkofski F; Lencer R; Münchau A; Klein C
    Arch Neurol; 2006 Jun; 63(6):833-8. PubMed ID: 16769864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial Hyperkalemia and Hypertension (FHHt) and KLHL3: Description of a Family with a New Recessive Mutation (S553L) Compared to a Family with a Dominant Mutation, Q309R, with Analysis of Urinary Sodium Chloride Cotransporter.
    Kliuk-Ben Bassat O; Carmon V; Hanukoglu A; Ganon L; Massalha E; Holtzman EJ; Farfel Z; Mayan H
    Nephron; 2017; 137(1):77-84. PubMed ID: 28511177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
    Hashimoto Y; Matsuoka M
    J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
    Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
    Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.
    De Jonghe C; Cras P; Vanderstichele H; Cruts M; Vanderhoeven I; Smouts I; Vanmechelen E; Martin JJ; Hendriks L; Van Broeckhoven C
    Neurobiol Dis; 1999 Aug; 6(4):280-7. PubMed ID: 10448055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of early onset, familial Alzheimer's disease linked to chromosome 14.
    Mullan M; Bennett C; Figueredo C; Hughes D; Mant R; Owen M; Warren A; McInnis M; Marshall A; Lantos P
    Am J Med Genet; 1995 Feb; 60(1):44-52. PubMed ID: 7485234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Common to Rare Variants: The Genetic Component of Alzheimer Disease.
    Nicolas G; Charbonnier C; Campion D
    Hum Hered; 2016; 81(3):129-141. PubMed ID: 28002825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.